COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES
The present disclosure provides methods for treating hepatitis D virus (HDV) infection and/or an HDV-associated disease using combination therapies, and related kits and compositions for use in such methods. The components of the combination therapies may include one or more of an anti-HBV antibody;...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LAU, Audrey H GUPTA, Sneha V CHATTERGOON, Michael A CLOUTIER, Daniel J HWANG, Carey K ELIE, Sophia E |
description | The present disclosure provides methods for treating hepatitis D virus (HDV) infection and/or an HDV-associated disease using combination therapies, and related kits and compositions for use in such methods. The components of the combination therapies may include one or more of an anti-HBV antibody; an siRNA that targets an HBV mRNA; and a nucleos(t)ide reverse transcriptase inhibitor (NRTI).
La présente divulgation concerne des méthodes de traitement d'une infection par le virus de l'hépatite D (VHD) et/ou d'une maladie associée au VHD à l'aide de polythérapies, ainsi que des kits et des compositions associés destinés à être utilisés dans de telles méthodes. Les composants des polythérapies peuvent comprendre un ou plusieurs éléments parmi un anticorps anti-VHB ; un pARNi qui cible un ARNm de VHB ; et un inhibiteur de transcriptase inverse (NRTI) à base de nucléosides et de nucléotides. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023225599A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023225599A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023225599A33</originalsourceid><addsrcrecordid>eNqNi7sKwkAQANNYiPoPCzZaCHIhRcrjbuNtkduQ3cQyBDkr0UD8f3zgB1jNFDPLbHBcNyykxFHARg81amAvUHEL2qJViicI2LxFScBDT20nsAu-3wPFCt3n_a5WhB1ZRQ-eBK2grLPFdbzNafPjKttWqC4c0vQY0jyNl3RPz-HM5mhyY4qiLG2e_1e9AA8pM_k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES</title><source>esp@cenet</source><creator>LAU, Audrey H ; GUPTA, Sneha V ; CHATTERGOON, Michael A ; CLOUTIER, Daniel J ; HWANG, Carey K ; ELIE, Sophia E</creator><creatorcontrib>LAU, Audrey H ; GUPTA, Sneha V ; CHATTERGOON, Michael A ; CLOUTIER, Daniel J ; HWANG, Carey K ; ELIE, Sophia E</creatorcontrib><description>The present disclosure provides methods for treating hepatitis D virus (HDV) infection and/or an HDV-associated disease using combination therapies, and related kits and compositions for use in such methods. The components of the combination therapies may include one or more of an anti-HBV antibody; an siRNA that targets an HBV mRNA; and a nucleos(t)ide reverse transcriptase inhibitor (NRTI).
La présente divulgation concerne des méthodes de traitement d'une infection par le virus de l'hépatite D (VHD) et/ou d'une maladie associée au VHD à l'aide de polythérapies, ainsi que des kits et des compositions associés destinés à être utilisés dans de telles méthodes. Les composants des polythérapies peuvent comprendre un ou plusieurs éléments parmi un anticorps anti-VHB ; un pARNi qui cible un ARNm de VHB ; et un inhibiteur de transcriptase inverse (NRTI) à base de nucléosides et de nucléotides.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231221&DB=EPODOC&CC=WO&NR=2023225599A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231221&DB=EPODOC&CC=WO&NR=2023225599A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAU, Audrey H</creatorcontrib><creatorcontrib>GUPTA, Sneha V</creatorcontrib><creatorcontrib>CHATTERGOON, Michael A</creatorcontrib><creatorcontrib>CLOUTIER, Daniel J</creatorcontrib><creatorcontrib>HWANG, Carey K</creatorcontrib><creatorcontrib>ELIE, Sophia E</creatorcontrib><title>COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES</title><description>The present disclosure provides methods for treating hepatitis D virus (HDV) infection and/or an HDV-associated disease using combination therapies, and related kits and compositions for use in such methods. The components of the combination therapies may include one or more of an anti-HBV antibody; an siRNA that targets an HBV mRNA; and a nucleos(t)ide reverse transcriptase inhibitor (NRTI).
La présente divulgation concerne des méthodes de traitement d'une infection par le virus de l'hépatite D (VHD) et/ou d'une maladie associée au VHD à l'aide de polythérapies, ainsi que des kits et des compositions associés destinés à être utilisés dans de telles méthodes. Les composants des polythérapies peuvent comprendre un ou plusieurs éléments parmi un anticorps anti-VHB ; un pARNi qui cible un ARNm de VHB ; et un inhibiteur de transcriptase inverse (NRTI) à base de nucléosides et de nucléotides.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7sKwkAQANNYiPoPCzZaCHIhRcrjbuNtkduQ3cQyBDkr0UD8f3zgB1jNFDPLbHBcNyykxFHARg81amAvUHEL2qJViicI2LxFScBDT20nsAu-3wPFCt3n_a5WhB1ZRQ-eBK2grLPFdbzNafPjKttWqC4c0vQY0jyNl3RPz-HM5mhyY4qiLG2e_1e9AA8pM_k</recordid><startdate>20231221</startdate><enddate>20231221</enddate><creator>LAU, Audrey H</creator><creator>GUPTA, Sneha V</creator><creator>CHATTERGOON, Michael A</creator><creator>CLOUTIER, Daniel J</creator><creator>HWANG, Carey K</creator><creator>ELIE, Sophia E</creator><scope>EVB</scope></search><sort><creationdate>20231221</creationdate><title>COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES</title><author>LAU, Audrey H ; GUPTA, Sneha V ; CHATTERGOON, Michael A ; CLOUTIER, Daniel J ; HWANG, Carey K ; ELIE, Sophia E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023225599A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LAU, Audrey H</creatorcontrib><creatorcontrib>GUPTA, Sneha V</creatorcontrib><creatorcontrib>CHATTERGOON, Michael A</creatorcontrib><creatorcontrib>CLOUTIER, Daniel J</creatorcontrib><creatorcontrib>HWANG, Carey K</creatorcontrib><creatorcontrib>ELIE, Sophia E</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAU, Audrey H</au><au>GUPTA, Sneha V</au><au>CHATTERGOON, Michael A</au><au>CLOUTIER, Daniel J</au><au>HWANG, Carey K</au><au>ELIE, Sophia E</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES</title><date>2023-12-21</date><risdate>2023</risdate><abstract>The present disclosure provides methods for treating hepatitis D virus (HDV) infection and/or an HDV-associated disease using combination therapies, and related kits and compositions for use in such methods. The components of the combination therapies may include one or more of an anti-HBV antibody; an siRNA that targets an HBV mRNA; and a nucleos(t)ide reverse transcriptase inhibitor (NRTI).
La présente divulgation concerne des méthodes de traitement d'une infection par le virus de l'hépatite D (VHD) et/ou d'une maladie associée au VHD à l'aide de polythérapies, ainsi que des kits et des compositions associés destinés à être utilisés dans de telles méthodes. Les composants des polythérapies peuvent comprendre un ou plusieurs éléments parmi un anticorps anti-VHB ; un pARNi qui cible un ARNm de VHB ; et un inhibiteur de transcriptase inverse (NRTI) à base de nucléosides et de nucléotides.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2023225599A3 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE |
title | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS D VIRUS (HDV) INFECTION AND ASSOCIATED DISEASES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A42%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAU,%20Audrey%20H&rft.date=2023-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023225599A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |